Genome-wide aberrant DNA methylation of microRNA host genes in hepatocellular carcinoma

References

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61:69 - 90; http://dx.doi.org/10.3322/caac.20107; PMID: 21296855
   PubMed Web of Science ®Google Scholar
• Chuang SC, La Vecchia C, Boffetta P. Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett 2009; 286:9 - 14; http://dx.doi.org/10.1016/j.canlet.2008.10.040; PMID: 19091458
   PubMed Web of Science ®Google Scholar
• Mínguez B, Lachenmayer A. Diagnostic and prognostic molecular markers in hepatocellular carcinoma. Dis Markers 2011; 31:181 - 90; PMID: 22045404
   PubMed Web of Science ®Google Scholar
• Yasen M, Obulhasim G, Kajino K, Mogushi K, Mizushima H, Tanaka S, et al. DNA binding protein A expression and methylation status in hepatocellular carcinoma and the adjacent tissue. Int J Oncol 2012; 40:789 - 97; PMID: 22159460
   PubMed Web of Science ®Google Scholar
• Pereira B, Oliveira C, David L, Almeida R. CDX2 promoter methylation is not associated with mRNA expression. Int J Cancer 2009; 125:1739 - 42; http://dx.doi.org/10.1002/ijc.24544; PMID: 19569237
   PubMed Web of Science ®Google Scholar
• Shah N, Lin B, Sibenaller Z, Ryken T, Lee H, Yoon JG, et al. Comprehensive analysis of MGMT promoter methylation: correlation with MGMT expression and clinical response in GBM. PLoS One 2011; 6:e16146; http://dx.doi.org/10.1371/journal.pone.0016146; PMID: 21249131
   PubMedGoogle Scholar
• Formeister EJ, Tsuchiya M, Fujii H, Shpyleva S, Pogribny IP, Rusyn I. Comparative analysis of promoter methylation and gene expression endpoints between tumorous and non-tumorous tissues from HCV-positive patients with hepatocellular carcinoma. Mutat Res 2010; 692:26 - 33; http://dx.doi.org/10.1016/j.mrfmmm.2010.07.013; PMID: 20736025
   PubMed Web of Science ®Google Scholar
• Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120:15 - 20; http://dx.doi.org/10.1016/j.cell.2004.12.035; PMID: 15652477
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116:281 - 97; http://dx.doi.org/10.1016/S0092-8674(04)00045-5; PMID: 14744438
   PubMed Web of Science ®Google Scholar
• Pasquinelli AE, Hunter S, Bracht J. MicroRNAs: a developing story. Curr Opin Genet Dev 2005; 15:200 - 5; http://dx.doi.org/10.1016/j.gde.2005.01.002; PMID: 15797203
   PubMed Web of Science ®Google Scholar
• Carleton M, Cleary MA, Linsley PS. MicroRNAs and cell cycle regulation. Cell Cycle 2007; 6:2127 - 32; http://dx.doi.org/10.4161/cc.6.17.4641; PMID: 17786041
   PubMed Web of Science ®Google Scholar
• Garzon R, Calin GA, Croce CM. MicroRNAs in Cancer. Annu Rev Med 2009; 60:167 - 79; http://dx.doi.org/10.1146/annurev.med.59.053006.104707; PMID: 19630570
   PubMed Web of Science ®Google Scholar
• Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857 - 66; http://dx.doi.org/10.1038/nrc1997; PMID: 17060945
   PubMed Web of Science ®Google Scholar
• Braconi C, Patel T. MicroRNA expression profiling: a molecular tool for defining the phenotype of hepatocellular tumors. Hepatology 2008; 47:1807 - 9; http://dx.doi.org/10.1002/hep.22326; PMID: 18506877
   PubMed Web of Science ®Google Scholar
• Huang YS, Dai Y, Yu XF, Bao SY, Yin YB, Tang M, et al. Microarray analysis of microRNA expression in hepatocellular carcinoma and non-tumorous tissues without viral hepatitis. J Gastroenterol Hepatol 2008; 23:87 - 94; http://dx.doi.org/10.1111/j.1440-1746.2007.05223.x; PMID: 18171346
   PubMed Web of Science ®Google Scholar
• Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, Rebouissou S, et al. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 2008; 47:1955 - 63; http://dx.doi.org/10.1002/hep.22256; PMID: 18433021
   PubMed Web of Science ®Google Scholar
• Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S, Liu CG, et al. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 2007; 67:6092 - 9; http://dx.doi.org/10.1158/0008-5472.CAN-06-4607; PMID: 17616664
   PubMed Web of Science ®Google Scholar
• Kutay H, Bai S, Datta J, Motiwala T, Pogribny I, Frankel W, et al. Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem 2006; 99:671 - 8; http://dx.doi.org/10.1002/jcb.20982; PMID: 16924677
   PubMed Web of Science ®Google Scholar
• Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, Okanoue T, et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006; 25:2537 - 45; http://dx.doi.org/10.1038/sj.onc.1209283; PMID: 16331254
   PubMed Web of Science ®Google Scholar
• Wong QW, Lung RW, Law PT, Lai PB, Chan KY, To KF, et al. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. Gastroenterology 2008; 135:257 - 69; http://dx.doi.org/10.1053/j.gastro.2008.04.003; PMID: 18555017
   PubMed Web of Science ®Google Scholar
• Li W, Xie L, He X, Li J, Tu K, Wei L, et al. Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma. Int J Cancer 2008; 123:1616 - 22; http://dx.doi.org/10.1002/ijc.23693; PMID: 18649363
   PubMed Web of Science ®Google Scholar
• Saito Y, Jones PA. Epigenetic activation of tumor suppressor microRNAs in human cancer cells. Cell Cycle 2006; 5:2220 - 2; http://dx.doi.org/10.4161/cc.5.19.3340; PMID: 17012846
   PubMed Web of Science ®Google Scholar
• Weber B, Stresemann C, Brueckner B, Lyko F. Methylation of human microRNA genes in normal and neoplastic cells. Cell Cycle 2007; 6:1001 - 5; http://dx.doi.org/10.4161/cc.6.9.4209; PMID: 17457051
   PubMed Web of Science ®Google Scholar
• Saito Y, Liang G, Egger G, Friedman JM, Chuang JC, Coetzee GA, et al. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 2006; 9:435 - 43; http://dx.doi.org/10.1016/j.ccr.2006.04.020; PMID: 16766263
   PubMed Web of Science ®Google Scholar
• Saito Y, Friedman JM, Chihara Y, Egger G, Chuang JC, Liang G. Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells. Biochem Biophys Res Commun 2009; 379:726 - 31; http://dx.doi.org/10.1016/j.bbrc.2008.12.098; PMID: 19116145
   PubMed Web of Science ®Google Scholar
• Kunej T, Godnic I, Ferdin J, Horvat S, Dovc P, Calin GA. Epigenetic regulation of microRNAs in cancer: an integrated review of literature. Mutat Res 2011; 717:77 - 84; http://dx.doi.org/10.1016/j.mrfmmm.2011.03.008; PMID: 21420983
   PubMed Web of Science ®Google Scholar
• Alpini G, Glaser SS, Zhang JP, Francis H, Han Y, Gong J, et al. Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer. J Hepatol 2011; 55:1339 - 45; http://dx.doi.org/10.1016/j.jhep.2011.04.015; PMID: 21703189
   PubMed Web of Science ®Google Scholar
• Datta J, Kutay H, Nasser MW, Nuovo GJ, Wang B, Majumder S, et al. Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res 2008; 68:5049 - 58; http://dx.doi.org/10.1158/0008-5472.CAN-07-6655; PMID: 18593903
   PubMed Web of Science ®Google Scholar
• Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 2010; 31:766 - 76; http://dx.doi.org/10.1093/carcin/bgp250; PMID: 19843643
   PubMed Web of Science ®Google Scholar
• Huang J, Wang Y, Guo Y, Sun S. Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. Hepatology 2010; 52:60 - 70; http://dx.doi.org/10.1002/hep.23660; PMID: 20578129
   PubMed Web of Science ®Google Scholar
• Shen J, Wang S, Zhang YJ, Kappil M, Wu HC, Kibriya MG, et al. Genome-wide DNA methylation profiles in hepatocellular carcinoma. Hepatology 2012; 55:1799 - 808; http://dx.doi.org/10.1002/hep.25569; PMID: 22234943
   PubMed Web of Science ®Google Scholar
• Shu Y, Wang B, Wang J, Wang JM, Zou SQ. Identification of methylation profile of HOX genes in extrahepatic cholangiocarcinoma. World J Gastroenterol 2011; 17:3407 - 19; http://dx.doi.org/10.3748/wjg.v17.i29.3407; PMID: 21876633
   PubMed Web of Science ®Google Scholar
• Waltering KK, Porkka KP, Jalava SE, Urbanucci A, Kohonen PJ, Latonen LM, et al. Androgen regulation of micro-RNAs in prostate cancer. Prostate 2011; 71:604 - 14; http://dx.doi.org/10.1002/pros.21276; PMID: 20945501
   PubMed Web of Science ®Google Scholar
• Han L, Witmer PD, Casey E, Valle D, Sukumar S. DNA methylation regulates MicroRNA expression. Cancer Biol Ther 2007; 6:1284 - 8; PMID: 17660710
   PubMed Web of Science ®Google Scholar
• Matsushima K, Isomoto H, Kohno S, Nakao K. MicroRNAs and esophageal squamous cell carcinoma. Digestion 2010; 82:138 - 44; http://dx.doi.org/10.1159/000310918; PMID: 20588024
   PubMed Web of Science ®Google Scholar
• Hui AB, Lenarduzzi M, Krushel T, Waldron L, Pintilie M, Shi W, et al. Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res 2010; 16:1129 - 39; http://dx.doi.org/10.1158/1078-0432.CCR-09-2166; PMID: 20145181
   PubMed Web of Science ®Google Scholar
• Shen YL, Jiang YG, Greenlee AR, Zhou LL, Liu LH. MicroRNA expression profiles and miR-10a target in anti-benzo[a] pyrene-7, 8-diol-9, 10-epoxide-transformed human 16HBE cells. Biomed Environ Sci 2009; 22:14 - 21; http://dx.doi.org/10.1016/S0895-3988(09)60016-7; PMID: 19462682
   PubMed Web of Science ®Google Scholar
• Tan Y, Zhang B, Wu T, Skogerbø G, Zhu X, Guo X, et al. Transcriptional inhibiton of Hoxd4 expression by miRNA-10a in human breast cancer cells. BMC Mol Biol 2009; 10:12; http://dx.doi.org/10.1186/1471-2199-10-12; PMID: 19232136
   PubMed Web of Science ®Google Scholar
• Agirre X, Jiménez-Velasco A, San José-Enériz E, Garate L, Bandrés E, Cordeu L, et al. Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth. Mol Cancer Res 2008; 6:1830 - 40; http://dx.doi.org/10.1158/1541-7786.MCR-08-0167; PMID: 19074828
   PubMed Web of Science ®Google Scholar
• Abe M, Hamada J, Takahashi O, Takahashi Y, Tada M, Miyamoto M, et al. Disordered expression of HOX genes in human non-small cell lung cancer. Oncol Rep 2006; 15:797 - 802; PMID: 16525661
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhu T, Chen Y, Mertani HC, Lee KO, Lobie PE. Human growth hormone-regulated HOXA1 is a human mammary epithelial oncogene. J Biol Chem 2003; 278:7580 - 90; http://dx.doi.org/10.1074/jbc.M212050200; PMID: 12482855
   PubMed Web of Science ®Google Scholar
• Mohankumar KM, Xu XQ, Zhu T, Kannan N, Miller LD, Liu ET, et al. HOXA1-stimulated oncogenicity is mediated by selective upregulation of components of the p44/42 MAP kinase pathway in human mammary carcinoma cells. Oncogene 2007; 26:3998 - 4008; http://dx.doi.org/10.1038/sj.onc.1210180; PMID: 17213808
   PubMed Web of Science ®Google Scholar
• Fang Y, Shi C, Manduchi E, Civelek M, Davies PF. MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro. Proc Natl Acad Sci U S A 2010; 107:13450 - 5; http://dx.doi.org/10.1073/pnas.1002120107; PMID: 20624982
   PubMed Web of Science ®Google Scholar
• Qin B, Yang H, Xiao B. Role of microRNAs in endothelial inflammation and senescence. Mol Biol Rep 2012; 39:4509 - 18; http://dx.doi.org/10.1007/s11033-011-1241-0; PMID: 21952822
   PubMed Web of Science ®Google Scholar
• Hernando E. microRNAs and cancer: role in tumorigenesis, patient classification and therapy. Clin Transl Oncol 2007; 9:155 - 60; http://dx.doi.org/10.1007/s12094-007-0029-0; PMID: 17403626
   PubMed Web of Science ®Google Scholar
• Ohuchida K, Mizumoto K, Lin C, Yamaguchi H, Ohtsuka T, Sato N, et al. MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene. Ann Surg Oncol 2012; 19:2394 - 402; http://dx.doi.org/10.1245/s10434-012-2252-3; PMID: 22407312
   PubMed Web of Science ®Google Scholar
• Foley NH, Bray I, Watters KM, Das S, Bryan K, Bernas T, et al. MicroRNAs 10a and 10b are potent inducers of neuroblastoma cell differentiation through targeting of nuclear receptor corepressor 2. Cell Death Differ 2011; 18:1089 - 98; http://dx.doi.org/10.1038/cdd.2010.172; PMID: 21212796
   PubMed Web of Science ®Google Scholar
• Varnholt H, Drebber U, Schulze F, Wedemeyer I, Schirmacher P, Dienes HP, et al. MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology 2008; 47:1223 - 32; http://dx.doi.org/10.1002/hep.22158; PMID: 18307259
   PubMed Web of Science ®Google Scholar
• Jiang J, Gusev Y, Aderca I, Mettler TA, Nagorney DM, Brackett DJ, et al. Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res 2008; 14:419 - 27; http://dx.doi.org/10.1158/1078-0432.CCR-07-0523; PMID: 18223217
   PubMed Web of Science ®Google Scholar
• Vrba L, Garbe JC, Stampfer MR, Futscher BW. Epigenetic regulation of normal human mammary cell type-specific miRNAs. Genome Res 2011; 21:2026 - 37; http://dx.doi.org/10.1101/gr.123935.111; PMID: 21873453
   PubMed Web of Science ®Google Scholar
• Li J, Smyth P, Flavin R, Cahill S, Denning K, Aherne S, et al. Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells. BMC Biotechnol 2007; 7:36; http://dx.doi.org/10.1186/1472-6750-7-36; PMID: 17603869
   PubMed Web of Science ®Google Scholar
• Xi Y, Nakajima G, Gavin E, Morris CG, Kudo K, Hayashi K, et al. Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA 2007; 13:1668 - 74; http://dx.doi.org/10.1261/rna.642907; PMID: 17698639
   PubMed Web of Science ®Google Scholar
• Balic M, Pichler M, Strutz J, Heitzer E, Ausch C, Samonigg H, et al. High quality assessment of DNA methylation in archival tissues from colorectal cancer patients using quantitative high-resolution melting analysis. J Mol Diagn 2009; 11:102 - 8; http://dx.doi.org/10.2353/jmoldx.2009.080109; PMID: 19179456
   PubMed Web of Science ®Google Scholar
• Harbeck N, Nimmrich I, Hartmann A, Ross JS, Cufer T, Grützmann R, et al. Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients. J Clin Oncol 2008; 26:5036 - 42; http://dx.doi.org/10.1200/JCO.2007.14.1697; PMID: 18711169
   PubMed Web of Science ®Google Scholar
• Bai S, Nasser MW, Wang B, Hsu SH, Datta J, Kutay H, et al. MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib. J Biol Chem 2009; 284:32015 - 27; http://dx.doi.org/10.1074/jbc.M109.016774; PMID: 19726678
   PubMed Web of Science ®Google Scholar
• Barrett T, Troup DB, Wilhite SE, Ledoux P, Rudnev D, Evangelista C, et al. NCBI GEO: archive for high-throughput functional genomic data. Nucleic Acids Res 2009; 37:Database issue D885 - 90; http://dx.doi.org/10.1093/nar/gkn764; PMID: 18940857
   PubMed Web of Science ®Google Scholar
• Bibikova M, Lin Z, Zhou L, Chudin E, Garcia EW, Wu B, et al. High-throughput DNA methylation profiling using universal bead arrays. Genome Res 2006; 16:383 - 93; http://dx.doi.org/10.1101/gr.4410706; PMID: 16449502
   PubMed Web of Science ®Google Scholar
• Mi H, Dong Q, Muruganujan A, Gaudet P, Lewis S, Thomas PD. PANTHER version 7: improved phylogenetic trees, orthologs and collaboration with the Gene Ontology Consortium. Nucleic Acids Res 2010; 38:Database issue D204 - 10; http://dx.doi.org/10.1093/nar/gkp1019; PMID: 20015972
   PubMed Web of Science ®Google Scholar
• Zhang YJ, Chen CJ, Lee CS, Haghighi B, Yang GY, Wang LW, et al. Aflatoxin B1-DNA adducts and hepatitis B virus antigens in hepatocellular carcinoma and non-tumorous liver tissue. Carcinogenesis 1991; 12:2247 - 52; http://dx.doi.org/10.1093/carcin/12.12.2247; PMID: 1721008
   PubMed Web of Science ®Google Scholar